Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Romaric Larcher

18PUBLICATIONS

37CO-AUTHORS

Disease surveillanceMedical infection agents (incl. prions)Host-parasite interactionsMedical bacteriologyCross-sectional analysis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Apr 17, 2026

Real-world validation of a reduced-dose continuous infusion cefepime regimen: pharmacodynamic target attainment, efficacy and neurotoxicity.

|Jan 03, 2026

Continuous Infusion of Aztreonam-Avibactam After High Loading Dose for an Infection Caused by an OXA-48- and NDM-1-Co-producing ST147 Klebsiella pneumoniae.

Paul Laffont-Lozes, Fanny Villa, Céline Mory

|Oct 28, 2025

Correlation Between Antimicrobial Consumption and Resistance in <i>Klebsiella pneumoniae</i> During the COVID-19 Pandemic Using Dynamic Regression Models: A Quasi-Experimental Epidemiological Time-Series Study.

Paul Laffont-Lozes, Florian Salipante, Paul Loubet

|May 28, 2025

Phage therapy in patients with urinary tract infections: a systematic review.

|Apr 29, 2025

Real-Life Cefiderocol Use in Bone and Joint Infection: A French National Cohort.

Ava Diarra, Maxime Degrendel, Isabelle Eberl

|Jan 26, 2024

Weaning from Kidney Replacement Therapy in the Critically Ill Patient with Acute Kidney Injury.

Kada Klouche, Vincent Brunot, Romaric Larcher

Pageof 3

Frequent Collaborators

6 joint publications

Albert Sotto

5 joint publications

Paul Loubet

5 joint publications

Jean-Philippe Lavigne

3 joint publications

Anne-Marie Dupuy

3 joint publications

Alix Pantel

2 joint publications

Kada Klouche

2 joint publications

Vincent Brunot

2 joint publications

Jean-Paul Cristol

2 joint publications

Florian Salipante

1 joint publications

Sylvain Goutelle

Frequent Collaborators

6 joint publications

Albert Sotto

5 joint publications

Paul Loubet

5 joint publications

Jean-Philippe Lavigne

3 joint publications

Anne-Marie Dupuy

Top Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant <em>Clostridium difficile</em> Strain R20291

Cefoperazone-treated Mouse Model of Clinically-relevant <em>Clostridium difficile</em> Strain R20291

Published on : Dec 10, 2016

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on : Apr 18, 2019

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or <em>A. baumannii</em>

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or <em>A. baumannii</em>

Published on : Jan 02, 2017

See more related videos

Top Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant <em>Clostridium difficile</em> Strain R20291

Cefoperazone-treated Mouse Model of Clinically-relevant <em>Clostridium difficile</em> Strain R20291

Published on : Dec 10, 2016

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on : Apr 18, 2019

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or <em>A. baumannii</em>

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or <em>A. baumannii</em>

Published on : Jan 02, 2017

See more related videos